Skip to content
naulon
Get started

No retraction, correction or concern found when last checked on Nov 1, 2026.

2015 update of the evidence base: World Allergy Organization anaphylaxis guidelines

F. Estelle R. Simons, Motohiro Ebisawa, Mario Sanchez-Borges and 8 more

World Allergy Organization Journal · 2015

doi:10.1186/s40413-015-0080-1

Abstract

The World Allergy Organization (WAO) Guidelines for the assessment and management of anaphylaxis provide a unique global perspective on this increasingly common, potentially life-threatening disease. Recommendations made in the original WAO Anaphylaxis Guidelines remain clinically valid and relevant, and are a widely accessed and frequently cited resource. In this 2015 update of the evidence supporting recommendations in the Guidelines, new information based on anaphylaxis publications from January 2014 through mid- 2015 is summarized. Advances in epidemiology, diagnosis, and management in healthcare and community settings are highlighted. Additionally, new information about patient factors that increase the risk of severe and/or fatal anaphylaxis and patient co-factors that amplify anaphylactic episodes is presented and new information about anaphylaxis triggers and confirmation of triggers to facilitate specific trigger avoidance and immunomodulation is reviewed. The update includes tables summarizing important advances in anaphylaxis research.

Shown for reading. Its publisher allows quoting it, not republishing it.

References 150

  1. 1.

    Simons FER, Ardusso LRF, Bilo MB, El-Gamal YM, Ledford DK, Ring J, et al. for the World Allergy Organization. World Allergy Organization guidelines for the assessment and management of anaphylaxis. J Allergy Clin Immunol. 2011;127:587–93. e1-e22.

    Not in our library10.1016/j.jaci.2011.01.038

  2. 2.

    Simons FER, Ardusso LRF, Bilo MB, Dimov V, Ebisawa M, El-Gamal YM, et al. for the World Allergy Organization. 2012 Update: World Allergy Organization (WAO) guidelines for the assessment and management of anaphylaxis. Curr Opin Allergy Clin Immunol. 2012;12:389-99.

    Not in our library10.1097/aci.0b013e328355b7e4

  3. 3.

    Simons FER, Ardusso LRF, Dimov V, Ebisawa M, El-Gamal YM, Lockey RF, et al. for the World Allergy Organization. World Allergy Organization anaphylaxis guidelines: 2013 update of the evidence base. Int Arch Allergy Immunol. 2013;162:193-204.

    Not in our library10.1159/000354543

  4. 4.
    International consensus on (ICON) anaphylaxis · 2014
    No notice
  5. 5.

    Muraro A, Roberts G, Worm M, Bilò MB, Brockow K, Fernández Rivas M, et al. Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology. Allergy. 2014;69:1026-45.

    Not in our library10.1111/all.12437

  6. 6.

    Lieberman P, Nicklas RA, Randolph C, Oppenheimer J, Bernstein D, Bernstein J, et al. Anaphylaxis – a practice parameter update 2015. Ann Allergy Asthma Immunol. (in press).

    Not in our library10.1016/j.anai.2015.07.019

  7. 7.

    Tejedor Alonso MA, Moro Moro M, Múgica García MV. Epidemiology of anaphylaxis. Clin Exp Allergy. 2015;45:1027-39.

    Not in our library10.1111/cea.12418

  8. 8.

    Wood RA, Camargo CA, Lieberman P, Sampson HA, Schwartz LB, Zitt M, et al. Anaphylaxis in America: The prevalence and characteristics of anaphylaxis in the United States. J Allergy Clin Immunol. 2014;133:461-7.

    Not in our library10.1016/j.jaci.2013.08.016

  9. 9.

    Rudders SA, Arias SA, Camargo CA. Trends in hospitalizations for food-induced anaphylaxis in US children, 2000–2009. J Allergy Clin Immunol. 2014;134:960-2.

    Not in our library10.1016/j.jaci.2014.06.018

  10. 10.

    Nocerino R, Leone L, Cosenza L, Canani RB. Increasing rate of hospitalizations for food-induced anaphylaxis in Italian children: an analysis of the Italian Ministry of Health database. J Allergy Clin Immunol. 2015;135:833-35.

    Not in our library10.1016/j.jaci.2014.12.1912

  11. 11.

    Mullins RJ, Dear KBG, Tang MLK. Time trends in Australian hospital anaphylaxis admissions in 1998–1999 to 2011–2012. J Allergy Clin Immunol. 2015;136:367-375.

    Not in our library10.1016/j.jaci.2015.05.009

  12. 12.
    Increase in anaphylaxis-related hospitalizations but no increase in fatalities: An analysis of United Kingdom national anaphylaxis data, 1992-2012 · 2015
    No notice
  13. 13.

    Ma L, Danoff TM, Borish L. Case fatality and population mortality associated with anaphylaxis in the United States. J Allergy Clin Immunol. 2014;133:1075-83.

    Not in our library10.1016/j.jaci.2013.10.029

  14. 14.

    Jerschow E, Lin RY, Scaperotti MM, McGinn AP. Fatal anaphylaxis in the United States, 1999–2010: Temporal patterns and demographic associations. J Allergy Clin Immunol. 2014;134:1318-28.

    Not in our library10.1016/j.jaci.2014.08.018

  15. 15.

    Tanno LK, Calderon MA, Goldberg BJ, Akdis CA, Papadopoulos NG, Demoly P. Categorization of allergic disorders in the new World Health Organization International Classification of Diseases. Clin Transl. Allergy. 2014;4:42.

    Not in our library10.1186/2045-7022-4-42

  16. 16.

    Tanno LK, Calderon MA, Goldberg BJ, Gayraud J, Bircher AJ, Casale T, et al. Constructing a classification of hypersensitivity/allergic diseases for ICD-11 by crowdsourcing the allergist community. Allergy. 2015;70:609-15.

    Not in our library10.1111/all.12604

  17. 17.

    Clark S, Wei W, Rudders SA, Camargo CA. Risk factors for severe anaphylaxis in patients receiving anaphylaxis treatment in US emergency departments and hospitals. J Allergy Clin Immunol. 2014;134:1125-30.

    Not in our library10.1016/j.jaci.2014.05.018

  18. 18.

    Ye YM, Kim MK, Kang HR, Kim TB, Sohn SW, Koh YI, et al. for the KAAACI Work Group on Urticaria/Angioedema/Anaphylaxis. Predictors of the severity and serious outcomes of anaphylaxis in Korean adults: a multicenter retrospective case study. Allergy Asthma Immunol Res. 2015;7:22–9.

    Not in our library10.4168/aair.2015.7.1.22

  19. 19.

    Simons FER, Sampson HA. Anaphylaxis: Unique aspects of clinical diagnosis and management in infants (birth to age 2 years). J Allergy Clin Immunol. 2015;135:1125-31.

    Not in our library10.1016/j.jaci.2014.09.014

  20. 20.

    Vazquez-Ortiz M, Alvaro M, Piquer M, Giner MT, Dominguez O, Lozano J, et al. Life-threatening anaphylaxis to egg and milk oral immunotherapy in asthmatic teenagers. Ann Allergy Asthma Immunol. 2014;113:482-4.

    Not in our library10.1016/j.anai.2014.07.010

  21. 21.

    Rutkowski K, Nasser SM. Management of hypersensitivity reactions to anti-D immunoglobulin preparations. Allergy. 2014;69:1560-3.

    Not in our library10.1111/all.12494

  22. 22.

    Triggiani M, Montagni M, Parente R, Ridolo E. Anaphylaxis and cardiovascular diseases: a dangerous liaison. Curr Opin Allergy Clin Immunol. 2014;14:309-15.

    Not in our library10.1097/aci.0000000000000071

  23. 23.

    Lieberman P, Simons FER. Anaphylaxis and cardiovascular disease: therapeutic dilemmas. Clin Exp Allergy. 2015;45:1288-95.

    Not in our library10.1111/cea.12520

  24. 24.

    Rueff F, Vos B, Oude Elberink J, Bender A, Chatelain R, Dugas-Breit S, et al. Predictors of clinical effectiveness of Hymenoptera venom immunotherapy. Clin Exp Allergy. 2014;44:736-46.

    Not in our library10.1111/cea.12275

  25. 25.

    Stoevesandt J, Hain J, Stolze I, Kerstan A, Trautmann A. Angiotensin-converting enzyme inhibitors do not impair the safety of Hymenoptera venom immunotherapy build-up phase. Clin Exp Allergy. 2014;44:747-55.

    Not in our library10.1111/cea.12276

  26. 26.

    Nassiri M, Babina M, Dölle S, Edenharter G, Ruëff F, Worm M. Ramipril and metoprolol intake aggravate human and murine anaphylaxis: Evidence for direct mast cell priming. J Allergy Clin Immunol. 2015;135:491-9.

    Not in our library10.1016/j.jaci.2014.09.004

  27. 27.

    Valent P. Risk factors and management of severe life-threatening anaphylaxis in patients with clonal mast cell disorders. Clin Exp Allergy. 2014;44:914-20.

    Not in our library10.1111/cea.12318

  28. 28.

    Gulen T, Hagglund H, Sander B, Dahlen B, Nilsson G. The presence of mast cell clonality in patients with unexplained anaphylaxis. Clin Exp Allergy. 2014;44:1179-87.

    Not in our library10.1111/cea.12369

  29. 29.

    Alvarez-Twose I, Zanotti R, Gonzalez-de-Olano D, Bonadonna P, Vega A, Matito A, et al. Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM. J Allergy Clin Immunol. 2014;133:520-8.

    Not in our library10.1016/j.jaci.2013.06.020

  30. 30.

    Broesby-Olsen S, Oropeza AR, Bindslev-Jensen C, Vestergaard H, Møller MB, Siebenhaar F, et al. Recognizing mastocytosis in patients with anaphylaxis: Value of KIT D816V mutation analysis of peripheral blood. J Allergy Clin Immunol. 2015;135:262-4.

    Not in our library10.1016/j.jaci.2014.06.031

  31. 31.

    Fellinger C, Hemmer W, Wohrl S, Sesztak-Greinecker G, Jarisch R, Wantke F. Clinical characteristics and risk profile of patients with elevated baseline serum tryptase. Allergol Immunopathol (Madr). 2014;42:544-52.

    Not in our library10.1016/j.aller.2014.05.002

  32. 32.

    Pravettoni V, Piantanida M, Primavesi L, Forti S, Pastorello EA. Basal platelet-activating factor acetylhydrolase: Prognostic marker of severe Hymenoptera venom anaphylaxis. J Allergy Clin Immunol. 2014;133:1218-20.

    Not in our library10.1016/j.jaci.2013.10.033

  33. 33.

    Lyons JJ, Sun G, Stone KD, Nelson C, Wisch L, O’Brien M, et al. Mendelian inheritance of elevated serum tryptase associated with atopy and connective tissue abnormalities. J Allergy Clin Immunol. 2014;133:1471-4.

    Not in our library10.1016/j.jaci.2013.11.039

  34. 34.

    Fischer J, Hebsaker J, Caponetto P, Platts-Mills TA, Biedermann T. Galactose-alpha-1,3-galactose sensitization is a prerequisite for pork-kidney allergy and cofactor-related mammalian meat anaphylaxis. J Allergy Clin Immunol. 2014;134:755-9.

    Not in our library10.1016/j.jaci.2014.05.051

  35. 35.

    Ansley L, Bonini M, Delgado L, Del Giacco S, Du Toit G, Khaitov M, et al. Pathophysiological mechanisms of exercise-induced anaphylaxis: an EAACI position statement. Allergy. 2015;70:1212-21.

    Not in our library10.1111/all.12677

  36. 36.

    Brockow K, Kneissl D, Valentini L, Zelger O, Grosber M, Kugler C, et al. Using a gluten oral food challenge protocol to improve diagnosis of wheat-dependent exercise-induced anaphylaxis. J Allergy Clin Immunol. 2015;135:977-84.

    Not in our library10.1016/j.jaci.2014.08.024

  37. 37.

    Hox V, Desai A, Bandara G, Gilfillan AM, Metcalfe DD, Olivera A. Estrogen increases the severity of anaphylaxis in female mice through enhanced endothelial nitric oxide synthase expression and nitric oxide production. J Allergy Clin Immunol. 2015;135:729-36.

    Not in our library10.1016/j.jaci.2014.11.003

  38. 38.

    Worm M, Moneret-Vautrin A, Scherer K, Lang R, Fernandez-Rivas M, Cardona V, et al. First European data from the network of severe allergic reactions (NORA). Allergy. 2014;69:1397-404.

    Not in our library10.1111/all.12475

  39. 39.

    Sicherer SH, Sampson HA. Food allergy: epidemiology, pathogenesis, diagnosis, and treatment. J Allergy Clin Immunol. 2014;133:291-307.

    Not in our library10.1016/j.jaci.2013.11.020

  40. 40.

    Sampson HA, Aceves S, Bock SA, James J, Jones S, Lang D, et al. Food allergy: a practice parameter update - 2014. J Allergy Clin Immunol. 2014;134:1016-25.

    Not in our library10.1016/j.jaci.2014.05.013

All 150 references

Cited by papers we hold 5

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.